2003
DOI: 10.1016/s1353-8020(03)00063-4
|View full text |Cite
|
Sign up to set email alerts
|

Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
16
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(17 citation statements)
references
References 42 publications
1
16
0
Order By: Relevance
“…Although both the prefrontal cortex and the striatum receive dopaminergic innervation, the striatum receives a far denser projection and the input is from the substantia nigra pars compacta, which undergoes selective and extensive neurodegeneration in PD (Moore, 2003;Seamans and Yang, 2004). In addition, evidence suggests that dopaminergic neurodegeneration may begin with loss of striatal nerve terminals and a 'dying back' process (Dauer and Przedborski, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Although both the prefrontal cortex and the striatum receive dopaminergic innervation, the striatum receives a far denser projection and the input is from the substantia nigra pars compacta, which undergoes selective and extensive neurodegeneration in PD (Moore, 2003;Seamans and Yang, 2004). In addition, evidence suggests that dopaminergic neurodegeneration may begin with loss of striatal nerve terminals and a 'dying back' process (Dauer and Przedborski, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopamine containing neurons primarily within the substantia nigra pars compacta of the midbrain (Obeso et al, 2000;Moore, 2003). The disease is typically characterised and diagnosed by a syndrome of bradykinesia, tremor, and muscular rigidity (Stern, 1988;Gelb, Oliver & Gilman, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…137,138 A hallmark of PD is gliosis and degeneration of dopaminergic neurons in the substantia nigra are not the only features of PD. It also involves selective denervation, 139 dysfunctions in the mitochondrial and ubiquitin-proteosome system, and oxidative and nitrosative stress. 140 Available drugs for PD neither surpass nor reverse disease progression 141 and BBB causes additional challenge in drug delivery.…”
Section: Parkinson Diseasementioning
confidence: 99%